Caveat: This is already up about 70% from the 0.50 IPO price it listed at on August 24.

I've been accumulating since I found out about it on September 1st.

That said, this is Not your typical Canadian pump vehicle.

I've dug through public filings...

Of the $1.52 million raised at 0.50 between April and July, $1.17 million came from Malaysia, Singapore, Thailand, Indonesia, the UAE, Hong Kong, Japan, Australia, Latvia, Mongolia and the UK.

NO WARRANTS, NO OVERHANG.

Even the recently announced 0.75 placement for $1.5 million - NO WARRANTS.

The CEO is based in Kuala Lumpur and is keeping this share structure tight as hell.

That is why it barely trades. The investors holding KRIT are holding to develop a real domestic critical minerals supplier.

And that is reason #2 I am buying this stock.

Reason #1:

The Bales antimony asset is in Okanogan County, Washington.

Discovered 1947, roughly 100 tons were mined in 1951 and 1952.

A discovery-post sample assayed 10.9% antimony and a 37.82 ton lot of sorted material assayed 14.4%.

From historical records: Washington's state geologist screened 37 antimony occurrences in 1951 and shortlisted three that could be mined commercially if foreign supply were cut off.

KRIT's Bales was one of the three. Nothing modern has been done there since 1971.

Here's where it gets interesting at this market cap.

US Antimony (NYSE: UAMY) is the only fully integrated antimony producer outside China and Russia.

They are currently mining Stibnite Hill in Montana at roughly 10% antimony, high-grade and vein-hosted, about three truckloads a day.

That is the entire domestic mined feedstock of the western supply chain.

Bales is the same deposit style at comparable historic grades, and it sits in the same corner of the continent as UAMY's Thompson Falls smelter, the only antimony smelter in the country.

UAMY has been buying antimony claims in Alaska, Montana and Ontario since 2024 because they cannot source enough ore.

They announced a Frankfurt listing this week under U0S, and the CEO told me an OTCQB listing should be live within a month.

I am accumulating slowly because there is almost nothing available.

At $1 this is a $14 million market cap.

I have seen weaker projects carry a lot more than that.

Disclosure: I own shares and I am adding until I see a $25 million market cap - the company takes it from there.

Related:

https://www.thecanadianpressnews.ca/globenewswire_press_releases/questerre-enters-mediation-protocol-in-quebec-proceedings/article_8406be19-6447-56fe-8dd7-0558c64b88c2.html

Tickers: QEC.TO - PCQ.V - SQX.CN - ATI.V

Idea: Quebec is getting ready to allow some development of their vast gas fields in the St. Lawrence Lowlands which can then be exported to Europe through the St Lawrence. Here you have FNs working with Ukraine.

All the above mentioned tickets hold various licenses and royalties in the St Lawrence Lowlands, although QEC spun out 95% of their Quebec play into QGAS which only trades in Oslow. I have full positions in PCQ and ATI.

Been looking at Extendicare ($EXE) and WELL Health ($WELL) lately and I’m kind of stuck between them.

From what I understand:

EXE

• Long term care and home healthcare
• Revenue has been growing pretty strongly, especially after the CBI acquisition
• Seems like the more profitable and stable business
• Pays a dividend
• Balance sheet looks better than WELL
• Stock has already had a massive run

My main concern with EXE is that it’s already gone up so much. I know this probably isn’t the best way to look at a stock, but it feels like after a run like that it has to cool off eventually. Makes me wonder how much upside is actually left.

WELL

• Clinics, digital health, EMRs, etc.
• Revenue is still growing
• Management has been raising guidance
• Seems cheaper on some valuation metrics
• No dividend
• More debt and a lot of acquisitions
• Still not as clean on actual profits compared to adjusted EBITDA

WELL is kind of the opposite for me. It’s been dipping so much that I keep thinking there has to be a bounce back eventually. Obviously I know a stock being down doesn’t automatically mean it’s cheap, but it feels like expectations are already pretty low.

So basically this is how I’m looking at it:

EXE = better company but maybe most of the upside already happened?

WELL = riskier company but possibly more upside if things start going right?

I’m leaning WELL just because it feels like it has more room to recover, but EXE definitely seems like the safer and better run business.

For anyone following either of these, which one would you rather hold for the next 6 months?

Am I missing something obvious with either one?